Clinical Trial Update: A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating safety of combining Ontak (denileukin diftitox) with CHOP in Peripheral T-cell lymphoma. Results have been posted following study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• ONTAK (denileukin diftitox)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Yale University | Conditions: Peripheral T-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-02-10